Main menu

Pages

UK Medicines Regulatory Agency approves Moderna vaccine for children aged 12-17 years


The British Medicines Regulatory Agency has approved the Moderna vaccine for the Corona virus for children in the United Kingdom between the ages of 12 and 17, as the Medicines and Healthcare products Regulatory Agency announced, today, Tuesday, an extension of the license to use the vaccine called Spikevax, after studies concluded that it is safe to use. , according to The Independent.


 Britain's Medicines and Healthcare products Regulatory Agency (MHRA) said it was now up to the Joint Committee on Vaccination and Immunization (JCVI) to advise the government on whether the injection should be given to children in this age group.


The Medicines and Healthcare products Regulatory Agency (MHRA) said the vaccine, also known as Spikevax - "is safe and effective in this age group."


“I am pleased to confirm that the Corona vaccine manufactured by Moderna is now licensed for 12-17 year olds,” said Dr. John Ren, CEO of the Medicines and Healthcare products Regulatory Agency (MHRA), explaining that they have a comprehensive strategy to monitor the safety of all approved Corona vaccines. From the United Kingdom, this monitoring will cover the age group of 12-17 years.


He added, "It is up to the Joint Committee on Immunization (JCVI) to advise on whether this age group should be vaccinated with the Corona vaccine manufactured by Moderna as part of the distribution programme."


He said a coronavirus vaccine will be offered to all 16-17-year-olds in the UK by August 23.

Comments